Nutropin AQ Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

Evaluate the Non-inferiority of Pain Intensity After the Application of Recombinant Human Somatropin - Biomatrop in Relation to Recombinant Human Somatropin - Hormotrop, Single Dose, in Healthy Subjects
Condition:   Evaluate Pain Intensity in Healthy Subjects Interventions:   Drug: Recombinant human growth hormone - Biomatrop;   Drug: Recombinant human growth hormone - Hormotrop Sponsor:   Ache Laboratorios Farmaceuticos S.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials

Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy Subjects
Condition:   Healthy Subjects Interventions:   Drug: Recombinant human growth hormone - Biomatrop;   Drug: Recombinant human growth hormone - Hormotrop Sponsor:   Ache Laboratorios Farmaceuticos S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2018 Category: Research Source Type: clinical trials